NCT05268666: A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors |
|
|
| Recruiting | 1/2 | 126 | US | JBI-802 | Jubilant Therapeutics Inc. | Locally Advanced Solid Tumor, Metastatic Solid Tumor | 12/24 | 08/25 | | |
| Not yet recruiting | 1 | 108 | US | Psilocybin, Psilocybine, Psilocibin, Filament Health Psilocybin, PEX010, Transcutaneous auricular Vagus Nerve Stimulation (taVNS), Sham taVNS, Treatment as Usual (TAU) | University of Wisconsin, Madison, Tiny Blue Dot Foundation | Healthy, Psychedelic Experiences, Vagus Nerve Stimulation | 07/27 | 10/27 | | |
| Recruiting | N/A | 166 | US | Novel Communication Intervention, Enhanced Usual Care Parent Education | Indiana University, National Cancer Institute (NCI) | End of Life, Communication, Cancer Metastatic | 04/25 | 04/25 | | |
| Recruiting | N/A | 5000 | US | | The University of Texas Health Science Center, Houston | Aortic Aneurysm, Aortic Dissection, Aortic Diseases | 01/37 | 01/37 | | |
